Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure
Open Access
- 1 August 2006
- journal article
- Published by Elsevier in Kidney International
- Vol. 70 (3), 496-506
- https://doi.org/10.1038/sj.ki.5001575
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged miceKidney International, 2005
- Septic shockThe Lancet, 2005
- Mechanisms of hydrazine toxicity in rat liver investigated by proteomics and multivariate data analysisProteomics, 2004
- Application of difference gel electrophoresis to the identification of inner medullary collecting duct proteinsAmerican Journal of Physiology-Renal Physiology, 2004
- Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged miceKidney International, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Meprin, a brush-border enzyme, plays an important role in hypoxic/ischemic acute renal tubular injury in rats1Kidney International, 2002
- Nitric Oxide Synthase Inhibition as Therapy for Sepsis: A Decade of PromiseSurgical Infections, 2001
- Identification of a Locus on Distal Mouse Chromosome 12 That Controls Resistance to Tumor Necrosis Factor-Induced Lethal ShockGenomics, 1999
- Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre studyNephrology Dialysis Transplantation, 1996